Skip to main content
. 2022 Mar 18;119(11):179–187. doi: 10.3238/arztebl.m2022.0133

Figure 1.

Figure 1

Mental health in the NAKO baseline survey and the COVID-19 special survey based on PHQ-9 (depressive symptoms) and GAD-7 (anxiety disorder). Means are shown on the left and frequencies are shown on the right by cut-off for moderate or severe disorder (each with 95% confidence interval); n = 161 787. The years 2014–2019 comprise the baseline survey (cross-sectional changes), the year 2020 comprise the COVID-19 special survey. The estimates were adjusted for age, gender and study center.

COV-19, COVID-19 special survey; GAD-7, Generalized Anxiety Disorder Scale-7; PHQ-9, Patient Health Questionnaire